US SB2134 | 2013-2014 | 113th Congress
Status
Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on March 13 2014 - 25% progression, died in committee
Action: 2014-03-13 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on March 13 2014 - 25% progression, died in committee
Action: 2014-03-13 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Act to Ban Zohydro - Ends the sale and distribution of pure hydrocodone bitartrate extended-release capsules (marketed as Zohydro ER) within 45 days by withdrawing approval for its new drug application. Prohibits the Commissioner of Food and Drugs (FDA) from approving any new drug application for the capsules unless they are formulated to prevent abuse.
Title
Act to Ban Zohydro
Sponsors
| Sen. Joe Manchin [D-WV] |
History
| Date | Chamber | Action |
|---|---|---|
| 2014-03-13 | Senate | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
Same As/Similar To
HB4241 (Same As) 2014-03-14 - Referred to the Subcommittee on Health.
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/113th-congress/senate-bill/2134/all-info |
| Text | https://www.congress.gov/113/bills/s2134/BILLS-113s2134is.pdf |
